GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

South Korea flag South Korea · Delayed Price · Currency is KRW
34,700
-7,500 (-17.77%)
Mar 4, 2026, 3:30 PM KST
-7.34%
Market Cap 1.48T
Revenue (ttm) 73.64B
Net Income (ttm) -59.72B
Shares Out 42.78M
EPS (ttm) -1,470.58
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 654,775
Average Volume 405,814
Open 39,950
Previous Close 42,200
Day's Range 34,500 - 41,500
52-Week Range 22,500 - 72,700
Beta 1.35
RSI 44.55
Earnings Date n/a

About GemVax&KAEL

GemVax&KAEL Co.,Ltd engages in the manufacturing and selling of coating resins and filters for semiconductors and display production in South Korea. The company offers CA filter and gas scrubber resins for pollution control in the semiconductor and display sectors. It also engages in the research and development of anti-cancer vaccines. The company was founded in 1998 and is headquartered in Daejeon, South Korea. [Read more]

Industry Industrial - Machinery
Sector Industrials
Founded 1998
Employees 182
Stock Exchange KOSDAQ
Ticker Symbol 082270
Full Company Profile

Financial Performance

In 2024, GemVax&KAEL's revenue was 62.69 billion, a decrease of -13.18% compared to the previous year's 72.21 billion. Losses were -87.22 billion, 220.9% more than in 2023.

Financial Statements

News

There is no news available yet.